| Literature DB >> 33847711 |
Alex H Krist1,2, Karina W Davidson3, Carol M Mangione4, Michael Cabana5, Aaron B Caughey6, Esa M Davis7, Katrina E Donahue8, Chyke A Doubeni9, John W Epling10, Martha Kubik11, Li Li12, Gbenga Ogedegbe13, Douglas K Owens14, Lori Pbert15, Michael Silverstein16, James Stevermer17, Chien-Wen Tseng18,19, John B Wong20.
Abstract
Importance: Vitamin D is a fat-soluble vitamin that performs an important role in calcium homeostasis and bone metabolism and also affects many other cellular regulatory functions outside the skeletal system. Vitamin D requirements may vary by individual; thus, no one serum vitamin D level cutpoint defines deficiency, and no consensus exists regarding the precise serum levels of vitamin D that represent optimal health or sufficiency. Objective: To update its 2014 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a systematic review on screening for vitamin D deficiency, including the benefits and harms of screening and early treatment. Population: Community-dwelling, nonpregnant adults who have no signs or symptoms of vitamin D deficiency or conditions for which vitamin D treatment is recommended. Evidence Assessment: The USPSTF concludes that the overall evidence on the benefits of screening for vitamin D deficiency is lacking. Therefore, the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults cannot be determined. Recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults. (I statement).Entities:
Year: 2021 PMID: 33847711 DOI: 10.1001/jama.2021.3069
Source DB: PubMed Journal: JAMA ISSN: 0098-7484 Impact factor: 56.272